EssilorLuxottica (ESLOY) Stock Forecast & Price Target

$159.40 +1.90 (+1.21%)

As of 03:11 PM Eastern

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 1 Analyst Ratings

Sell
0

Hold
1

Buy
0

Based on 1 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for ESLOY.

Consensus Price Target

N/A

Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

ESLOY Analyst Ratings Over Time

Type	Current Forecast 8/22/24 to 8/22/25	1 Month Ago 7/23/24 to 7/23/25	3 Months Ago 5/24/24 to 5/24/25	1 Year Ago 8/23/23 to 8/22/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Hold	Hold	Hold	Hold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

EssilorLuxottica Stock vs. The Competition

Type	EssilorLuxottica	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.79	2.53
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	N/A	13,073.03% Upside	10.88% Upside
News Sentiment Rating	Neutral News See Recent ESLOY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
1/29/2025	Royal Bank Of Canada 3 of 5 stars	P. Dadhania Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy
12/3/2024	UBS Group 3 of 5 stars	S. Tibaldi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:30 PM ET.

Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 18, 2025. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

The current stock price is around $146.52, which may present a buying opportunity for investors looking to enter at a lower price point.
EssilorLuxottica Société anonyme has recently experienced a significant increase in short interest, indicating that some investors are betting against the stock, which could lead to a short squeeze and potential price increase.
The company operates in a diverse market, offering a wide range of products including the latest lens technologies and eyewear brands, which can attract a broad customer base.
With a strong presence in both Professional Solutions and Direct to Consumer segments, EssilorLuxottica Société anonyme is well-positioned to capitalize on both B2B and B2C sales channels.
The company has a solid history of innovation in the eyewear industry, continuously developing new products that meet consumer needs, which can drive future growth.

EssilorLuxottica
Bear Case

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

The stock has recently seen a decline of about 1.2%, which may indicate short-term volatility and uncertainty in the market.
With a current ratio of 0.95, the company may face challenges in meeting its short-term liabilities, which could raise concerns about liquidity.
The significant increase in short interest could suggest that many investors are skeptical about the company's future performance, potentially leading to downward pressure on the stock price.
EssilorLuxottica Société anonyme operates in a highly competitive market, which may impact its market share and profitability if competitors introduce superior products.
The company's debt-to-equity ratio of 0.17 indicates a relatively low level of debt, but any increase in borrowing could affect its financial stability and investor confidence.

ESLOY Forecast - Frequently Asked Questions

: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ESLOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESLOY, but not buy additional shares or sell existing shares.
: According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Analysts like EssilorLuxottica less than other "medical" companies. The consensus rating for EssilorLuxottica is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ESLOY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (OTCMKTS:ESLOY) was last updated on 8/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EssilorLuxottica (ESLOY) Stock Forecast & Price Target